Related Experiment Videos
New vaccines against bacterial enteric infections
1Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1990
Summary
New vaccines for typhoid and cholera offer safer, long-lasting protection against enteric infections. These advancements include oral and injectable options, with the cholera vaccine also protecting against ETEC diarrhea.
Area of Science:
- Medical Microbiology
- Vaccinology
- Biotechnology
Background:
- Enteric infections pose a significant global health challenge.
- Recent advancements in basic research and biotechnology are driving innovation in vaccine development.
- Existing vaccines often have limitations in terms of side effects or efficacy.
Purpose of the Study:
- To review the impact of recent progress on vaccine development for enteric infections.
- To highlight newly available and emerging vaccines against common enteric pathogens.
- To discuss the safety, efficacy, and cross-protective benefits of novel vaccine candidates.
Main Methods:
- Review of recent scientific literature and vaccine development pipelines.
- Analysis of clinical trial data and immunological studies for new vaccines.
- Assessment of vaccine safety profiles and duration of protection.
Main Results:
- New oral and injectable typhoid vaccines with improved safety profiles are available.
- An oral cholera vaccine provides long-lasting protection and exhibits cross-reactivity against enterotoxigenic E. coli (ETEC).
- Development is progressing for oral killed ETEC vaccines and live attenuated vaccines for rotavirus, cholera, and shigellosis.
Conclusions:
- Substantial progress in biotechnology has led to impactful vaccine development for enteric infections.
- Novel vaccines offer improved safety, efficacy, and broader protection compared to older formulations.
- Continued research promises further advancements in preventing and controlling enteric diseases.